Improving Atopic Dermatitis Treatment for Adolescents - News CenterA JAK-selective inhibitor maintains symptom improvement and quality of life in adolescents with atopic dermatitis after 76 weeks, with proven safety.
Researchers find new strategies to help immunotherapy annihilate cancerCombining checkpoint inhibitors with targeted drugs like JAK inhibitors enhances immune system response in resistant cancer cases.